PTH-containing therapeutic/prophylactic agent for osteoporosis, characterized in that PTH is administered once a week at unit dose of 100 to 200 units

Details for Australian Patent Application No. 2010293488 (hide)

Owner Asahi Kasei Pharma Corporation

Inventors Shirae, Shinichiro; Nakamura, Yasuo; Masunaga, Yuiko; Nozaki, Yoshihide; Kobayashi, Nobuyuki; Kuroda, Tatsuhiko; Kato, Hiroki; Serada, Masashi; Hori, Kazuyoshi

Agent Watermark

Pub. Number AU-A-2010293488

PCT Pub. Number WO2011/030774

Priority 2009-208039 09.09.09 JP

Filing date 8 September 2010

Wipo publication date 17 March 2011

International Classifications

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 33/10 (2006.01) Medicinal preparations containing inorganic active ingredients

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

29 March 2012 PCT application entered the National Phase

  PCT publication WO2011/030774 Priority application(s): WO2011/030774

21 June 2012 Amendment Made

  The nature of the amendment is: Amend the invention title to read PTH-containing therapeutic/prophylactic agent for osteoporosis, characterized in that PTH is administered once a week in a unit dose of 100 to 200 units

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010293497-Method for controlling insect pest by vibration

2010293447-Anti-plant-virus agent